SEC ownership of Rain Oncology Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001724979.

Comparable stake leader

PERCEPTIVE ADVISORS LLC

Disclosed value leader

PERCEPTIVE ADVISORS LLC

Comparable rows

0/5

Latest evidence

09 Aug 2023

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
09 Aug 2023
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001724979
Issuer location
Newark, CA

Ownership snapshot

Top shareholders of Rain Oncology Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/5
Latest evidence
09 Aug 2023
3/4/5 Highest disclosed value: $3,009,293 5 rows are not safely comparable across share classes.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $3.01M.

0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 2
PERCEPTIVE ADVISORS LLC $3.01M
Boxer Capital, LLC $1.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-5 of 5 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
3/4/5
10%+ Owner
class O/S missing
$3,009,293
2,487,019 shares
07 Oct 2021
Boxer Capital, LLC
3/4/5
Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc.
class O/S missing
$1,394,177
1,152,212 shares
22 May 2023
Richard P. Bryce
3/4/5
Chief Medical Officer
class O/S missing
110,000 shares
15 Feb 2023
Nelson Cabatuan
3/4/5
VP of Finance & Admin
class O/S missing
65,325 shares
15 Feb 2023
Josephine Bruce
3/4/5
Principal Fin. & Acc. Officer
class O/S missing
10,800 shares
09 Aug 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Sep 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-16 of 16 reporting-owner rows connected to Rain Oncology Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
16
Largest Forms 3/4/5 holder
PERCEPTIVE ADVISORS LLC
Net 12M change
$0
Latest report
26 Jan 2024
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
PERCEPTIVE ADVISORS LLC 10%+ Owner $3,009,293 Mixed 07 Oct 2021
Boxer Capital, LLC Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc. $1,394,177 Mixed 22 May 2023
Davis Aaron I. Director $0 Mixed 26 Jan 2024
BVF PARTNERS L P/IL Director, Other* $0 Mixed 25 Jan 2024
Robert Doebele President, Chief Scientific Officer $0 Mixed 26 Jan 2024
Peter Radovich Director $0 Mixed 26 Jan 2024
Kevin Tang 10%+ Owner $0 Mixed 26 Jan 2024
Franklin M. Berger Director $0 Mixed 26 Jan 2024
Avanish Vellanki Chairman and CEO, Director $0 Mixed 26 Jan 2024
Gorjan Hrustanovic Director Mixed 26 Jan 2024
Stefani Wolff Director Mixed 26 Jan 2024
Richard P. Bryce Chief Medical Officer Mixed 15 Feb 2023
Erik Atkisson General Counsel and CCO Mixed 26 Jan 2024
Nelson Cabatuan VP of Finance & Admin Mixed 15 Feb 2023
Josephine Bruce Principal Fin. & Acc. Officer Mixed 09 Aug 2023
Tran B. Nguyen Director Mixed 26 Jan 2024

Recent insider transactions for Rain Oncology Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .